 |
Joanna C. Yang, MD, MPHAssistant Professor
|
Professional Focus
Dr. Yang specializes in the treatment of breast cancers and lymphomas. Through clinical care, research, and policy work, her goals are to improve long-term outcomes for all of her patients by improving efficacy, minimizing toxicity, ensuring treatment value and affordability, and exploring the potential synergies of radiation therapy with novel drugs.
Dr. Yang earned a medical degree from the Mount Sinai School of Medicine in New York City, where she graduated with Distinction in Research and Distinction in Education. She then completed a transitional year internship and radiation oncology residency at Memorial Sloan Kettering Cancer Center. At MSKCC, Dr. Yang served as chief resident and completed a lymphoma fellowship.
Dr. Yang has an MPH from the Harvard School of Public Health in the Clinical Effectiveness Track. She was selected as a Health Policy Fellow for the American Society of Clinical Oncology from 2017-2018 and remains active with ASCO as a member of the Clinical Practice Committee. She is also an active council member of the International Lymphoma Radiation Oncology Group.
Education
| 2004-2008 | Stanford University, Stanford, CA | BA | Program in Human Biology |
| 2008-2013 | Mount Sinai School of Medicine, New York, NY | MD | |
| 2016-2018 | Harvard T.H. Chan School of Public Health, Boston, MA | MPH | Clinical Effectiveness Track |
| 2013-2014 | Memorial Sloan Kettering Cancer Center, New York, NY | Transitional Year Intern | Medicine |
| 2016-2017 | Memorial Sloan Kettering Cancer Center, New York, NY | Lymphoma Fellow | Radiation Oncology |
| 2014-2018 | Memorial Sloan Kettering Cancer Center, New York, NY | Resident | Radiation Oncology |
| 2017-2018 | Memorial Sloan Kettering Cancer Center, New York, NY | Chief Resident | Radiation Oncology |
Professional Experience
| 2018-present | University of California, San Francisco | Assistant Professor | Radiation Oncology |
Awards & Honors
| 2006 | Leadership Fellow, Haas Center for Public Service, Stanford University, Stanford, CA |
| 2009 | Patricia S. Levinson Fellowship Award, Mount Sinai School of Medicine, New York, NY |
| 2012 | Young Oncologist Essay Award, American Radium Society |
| 2012 | Annual Meeting Scientific Abstract/Travel Award, American Society for Radiation Oncology |
| 2012 | Distinction in Research, Mount Sinai School of Medicine, New York, NY |
| 2012 | Distinction in Medical Education, Mount Sinai School of Medicine, New York, NY |
| 2013 | The Judith and Nathan Kase Humanities in Medicine Prize, Mount Sinai School of Medicine, New York, NY |
| 2013 | Alpha Omega Alpha, Mount Sinai School of Medicine, New York, NY |
| 2017 | Lacher Fellow, Mortimer J. Lacher Fellowship Program, Memorial Sloan Kettering Cancer Center, New York, NY |
Recent Significant Publications :
Jae GA, Lewkowitz AK, Yang JC, Shen L, Rahman A, and Del Toro G. Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents. Ethn Health. 2011 Aug-Oct;16(4-5):431-45.
Yang J, Shin S, Fowkes M, Krieger S, Strauchen JA, Smethurst M, and Demopoulos A. Teaching NeuroImages: lymphomatoid granulomatosis involving lung and brain in an immunocompetent woman. Case report. Neurology. 2011 Sep 27;77(13):e75-6.
Yang JC, Chou AJ, Oeffinger KC, La Quaglia MP, and Wolden SL. Clear cell sarcoma of the gastrointestinal tract after very low-dose therapeutic radiation therapy: a case report. J Pediatr Surg. 2012 Oct;47(10):1943-5.
Yang JC, Dharmarajan KV, Wexler LH, La Quaglia MP, Happersett L, and Wolden SL. Intensity-modulated radiation therapy with dose-painting to treat rhabdomyosarcoma. Int J Radiat Oncol Biol Phys.2012 Nov;84(3):e371-7.
Yang JC, Wexler LH, Meyers PA, and Wolden SL. Parameningeal rhabdomyosarcoma: outcomes and opportunities. Int J Radiat Oncol Biol Phys. 2013 Jan;85(1):e61-6.
Yang JC, Khakoo Y, Lightner DD, and Wolden SL. Phantosmia during radiation therapy: a report of 2 cases. J Child Neurol. 2013 Jun;28(6):791-4.
Yang JC, Wexler LH, Meyers PA, Happersett L, La Quaglia MP, and Wolden SL. Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases. Pediatr Blood Cancer. 2013 Oct;60(10):1616-20.
Yang JC, Terezakis SA, Dunkel IJ, Gilheeney SW, and Wolden SL. Intensity-modulated radiation therapy with dose painting: A brain sparing technique for intracranial germ cell tumors. Pediatr Blood Cancer 2016 Apr; 63(4):646-651.
Kumar A, Casulo C, Yahalom J, Schoder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH. Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. Blood. 2016;128(11):1458-64. doi: 10.1182/blood-2016-03-703470. PubMed PMID: 27458003; PMCID: PMC5025897.